Mesothelioma News

Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
This study is currently recruiting patients.Verified by Merck April 2007

Sponsored by:
Merck

Information provided by:
Merck

ClinicalTrials.gov Identifier:
NCT00128102

Purpose

This is […]

This study is currently recruiting patients.
Verified by M.D. Anderson Cancer Center November 2006

Sponsors and Collaborators:
M.D. Anderson Cancer Center
Novartis

Information provided by:
M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:
NCT00402766

Purpose
Primary Objective:1. To determine the maximum tolerated dose of the combination of […]

This study is currently recruiting patients.
Verified by Dana-Farber Cancer Institute January 2007

Sponsors and Collaborators:
Dana-Farber Cancer Institute
Massachusetts General Hospital
University of Chicago

Information provided by:
Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:
NCT00137826

Purpose
The purpose of this study is to determine whether the combination of […]

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) November 2006

Sponsors and Collaborators:
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00398138

Purpose

RATIONALE: Vaccines made from peptides may help the body […]

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) September 2006

Sponsored by:
Burzynski Research Institute

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00003508

Purpose
RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may […]

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) August 2006

Sponsors and Collaborators:
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00354393

Purpose
RATIONALE: Drugs used in chemotherapy, such as methotrexate, vinorelbine, and cisplatin, work in different ways to […]

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) July 2006

Sponsors and Collaborators:
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
North Central Cancer Treatment Group

Information provided by:
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:
NCT00101283

Purpose

RATIONALE: Drugs used in chemotherapy, […]

This study is currently recruiting patients.
Verified by Morphotek July 2006

Sponsored by:
Morphotek

Information provided by:
Morphotek

ClinicalTrials.gov Identifier:
NCT00325494

Purpose
The purpose of this study is to establish the safest doses of an investigational drug called MORAb-009 in subjects with pancreatic cancer, mesothelioma, or certain types […]